Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Bonnie K. Harrington, Susan O’Brien et al. · New England Journal of Medicine · 2015 · 891 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling Methods

DR Mould · CPT Pharmacometrics & Systems Pharmacology · 2013 · 880 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming

Lars Lindbom, Jakob Ribbing, E. Niclas Jonsson · Computer Methods and Programs in Biomedicine · 2004 · 730 citations

Computing, Computer Science, Programming Languages +1

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

Radojka M. Savić, Daniël M. Jonker, Thomas Kerbusch et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2007 · 497 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani et al. · The Lancet · 2017 · 448 citations · Full text

Medicine, Oncology, Pharmacotherapy +11